The expedited assessment that COVID-19 product applications are receiving could become permanent FDA practice, along with some remote clinical trial monitoring practices. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
